Peter Kaiser, M.D.
| Appointed: |
1997 |
| Gender: |
Male |
| Languages: |
English |
Ophthalmology
Biographical Sketch
Peter K. Kaiser, MD, is a Staff member of the vitreoretinal faculty of the Cole Eye Institute in the Department of Ophthalmology at Cleveland Clinic's main campus. He was appointed in 1997. Dr. Kaiser is the Founding Director of the Digital Optical Coherence Tomography (OCT) Reading Center at the Cole Eye Institute.
Dr. Kaiser received his medical degree magna cum laude from Harvard Medical School in Boston, Mass. He completed an internship in internal medicine at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary in Boston and a retinal fellowship at Bascom Palmer Eye Institute in Miami, Florida.
Actively involved in retinal clinical research, Dr. Kaiser is study chairman of 4 major, multi-center, international clinical trials and is a principal investigator in multiple other trials. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences.
Dr. Kaiser is a major contributor to medical literature having authored several ophthalmology texts, and more than 200 book chapters, original reports, electronic publications and abstracts. He is an associate editor of the American Journal of Ophthalmology, and serves on the editorial boards of Retina, Retina Today, Retinal Physician and Ocular Surgery News.
Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards, and is listed in the "Best Doctors in America" list. He is the team ophthalmologist for the Cleveland Browns (National Football League), Cleveland Cavaliers (National Basketball Association) and the Cleveland Indians (Major League Baseball).
Professional Highlights
- Editor-in-Chief, Current Concepts in Retina
- Founding Director, Digital OCT Reading Center (DOCTR)
- Associate Editor, American Journal of Ophthalmology
- Editorial board, Retina, Retina Today, Retinal Physician, Ocular Surgery News
- Associate Editor, International Ophthalmology Clinics
Education & Fellowships
| Medical School: | Harvard Medical School, Boston, MA |
|
| Internship: | Massachusetts General Hospital, Internal Medicine, Boston, MA |
| Residency: | Massachusetts Eye and Ear Infirmary, Ophthalmology, Boston, MA |
| Fellowship: | Bascom Palmer Eye Institute-Anne Bates Leach Eye Hospital, Ophthalmology, Miami, FL |
| Other Education: | (Undergraduate) Harvard College, Cambridge, MA |
Additional Training
- FELLOWSHIP: Bascom Palmer Eye Institute
Miami Florida
Medical retina and vitreoretinal surgery 1996-1997
- RESIDENCY: Massachusetts Eye and Ear Infirmary 1993-1996
Boston, MA
Ophthalmology
- INTERNSHIP: Massachusetts General Hospital 1992-1993
Boston MA
Internal Medicine
- MEDICAL SCHOOL: Harvard Medical School 1988-1992
Boston MA
Doctor of Medicine
- COLLEGE: Harvard College 1984-1988
Boston MA
Bachelor of Arts
Certifications
Specialty Interests
Vitreoretinal diseases, retinal detachment, diabetic retinopathy, endophthalmitis.
Innovations & Patents
- Pioneer in the use of, and developer of several new 23 gauge surgical techniques, which allow sutureless vitrectomy surgery with less pain and faster visual recovery or patients
- Pioneer in new vitrectomy systems that offer better flow rates, faster cutting speeds, and safer probes than current machines
- First MD to use a modified RNA interfering molecule to treat age-related macular degeneration; this technique and its technology was the first time it had been used in any disease after the discovery of RNAi received the Nobel Prize in Medicine
- Pioneer in the use of spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal diseases
Awards & Honors
- American Academy of Ophthalmology Senior Achievement Award (Senior Honor Award), 2008
- National Institute of Health, RO1 grant funding, 2005-present
- Who's Who in Executives and Professionals Listing National Register, West Islip NY, 2004- present
- American Society of Retina Specialists, Senior Achievement Award (Senior Honor Award), 2003
- American Society of Retina Specialists, Achievement Award (Honor Award), 2002
- Best Doctors in America listing, 2002 - present
- Best Doctors in Midwest listing, 2002-present
- Best Doctors in Cleveland listing, 2002-present
- American Academy of Ophthalmology Achievement Award (Honor Award), 2001
- Strathmore's Who's Who listing, 2000-present
- Study Chairman, DENALI Phase 3 Study
- Study Chairman, VERITAS Phase 3 Study
- Study Chairman, VIO Phase 3 Study
- Study Chairman, TargeGen Phase 1 Study
Professional Memberships
- Retina Society, 2003- present
- Pan-American Ophthalmology Association, 2000- present
- American Society of Retina Specialists (Vitreous Society), 2000 - present
- Cleveland Ophthalmological Society, 1997 - present
- International Academy of Sports Vision, 1997 - present
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/6/2008, Dr. Kaiser has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Kaiser receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Alcon Laboratories
- Novartis
- Oraya Therapeutics, Inc.
Fiduciary Role. Dr. Kaiser serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
